Christian Nolet
Direttore/Membro del Consiglio presso REVANCE THERAPEUTICS, INC.
Patrimonio netto: 213 307 $ in data 30/04/2024
Posizioni attive di Christian Nolet
Società | Posizione | Inizio | Fine |
---|---|---|---|
REVANCE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 16/07/2019 | - |
Independent Dir/Board Member | 16/07/2019 | - | |
JASPER THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 24/09/2021 | - |
Independent Dir/Board Member | 24/09/2021 | - | |
ARRIVENT BIOPHARMA, INC. | Direttore/Membro del Consiglio | 20/09/2023 | - |
Independent Dir/Board Member | 20/09/2023 | - | |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - | - |
California Society of Certified Public Accountants | Corporate Officer/Principal | - | - |
Storia della carriera di Christian Nolet
Precedenti posizioni note di Christian Nolet
Società | Posizione | Inizio | Fine |
---|---|---|---|
REGENETP, INC. | Direttore/Membro del Consiglio | 06/04/2020 | 12/01/2023 |
Independent Dir/Board Member | 06/04/2020 | 12/01/2023 | |
Polarityte, Inc. /Brauser/
Polarityte, Inc. /Brauser/ Financial ConglomeratesFinance Polarityte, Inc. is a private group led by Michael Brauser. | Direttore/Membro del Consiglio | 01/04/2020 | 01/01/2023 |
AMBRX INC | Direttore/Membro del Consiglio | 23/02/2021 | 01/11/2021 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | 01/01/2021 | 01/11/2021 |
Independent Dir/Board Member | 01/01/2021 | 01/11/2021 | |
░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░ ░░░░ ░░░░░░░░░░ ░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Christian Nolet
San Diego State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Bermuda | 2 |
Nuova-Zelanda | 2 |
Posizioni
Director/Board Member | 10 |
Independent Dir/Board Member | 6 |
Corporate Officer/Principal | 4 |
Settori
Health Technology | 7 |
Commercial Services | 5 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
REGENETP, INC. | Health Technology |
JASPER THERAPEUTICS, INC. | Finance |
ARRIVENT BIOPHARMA, INC. | Health Technology |
Aziende private | 10 |
---|---|
Viela Bio, Inc.
Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
California Society of Certified Public Accountants | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
Center for Drug Evaluation & Research | Government |
Polarityte, Inc. /Brauser/
Polarityte, Inc. /Brauser/ Financial ConglomeratesFinance Polarityte, Inc. is a private group led by Michael Brauser. | Finance |
- Borsa valori
- Insiders
- Christian Nolet
- Esperienza